Sponsor:
Skyline Therapeutics (US) Inc.
Code:
NCT05986864
Conditions
Neovascular Age-related Macular Degeneration
Eligibility Criteria
Sex: All
Age: 50+
Healthy Volunteers: Not accepted
Interventions
SKG0106
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Skyline Therapeutics (US) Inc. on 2025-01-09.